Skip to content

Management of Age-Related Auditory Decline and Early Warning of Its Co-occurring Dementia

Management of Age-Related Auditory Decline and Early Warning of Its Co-occurring Dementia

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07608640
Acronym
AHEAD
Enrollment
3000
Registered
2026-05-27
Start date
2026-05-25
Completion date
2028-12-31
Last updated
2026-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Age-related Hearing Loss, Dementia

Keywords

Dementia, Hearing Loss, Disease Burden, Cohort Study, Predictive Model

Brief summary

Against the backdrop of global population aging, age-related hearing loss (ARHL) has reached epidemic proportions and is increasingly recognized as an independent risk factor for cognitive decline and other major neurodegenerative diseases. This study aims to systematically develop an integrated framework for the early warning, precise assessment, and intervention management of ARHL. Using a national multicenter design, the project will establish a prospective cohort of more than 3,000 older adults. We will integrate multimodal data including audiological tests, cognitive function assessments, and blood biomarkers, and employ artificial intelligence and unsupervised machine learning methods to address critical bottlenecks in the field: the unclear mechanistic link between ARHL and cognitive decline, and the lack of validated predictive tools. Specifically, this study will: (1) develop data-driven clinical classification criteria for ARHL; (2) create a personalized "Hearing Health Clock" predictive model; (3) identify minimally invasive blood biomarkers for early detection of cognitive impairment; and (4) formulate a multidimensional early dementia screening program suitable for community-wide implementation. The findings will provide scientific evidence and practical tools for the prevention and control of hearing and cognitive health risks in older adults in China.

Interventions

OTHERNot applicable- observational study

Not applicable-observational study

Sponsors

Chinese PLA General Hospital
Lead SponsorOTHER
Beijing Youyi Hospital
CollaboratorUNKNOWN
Peking University People's Hospital
CollaboratorOTHER
Xuanwu Hospital, Beijing
CollaboratorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. Aged 60 years or older. 2. Clear consciousness and able to cooperate with all study assessments and examinations. 3. Permanent local residents who have lived in the area for at least 9 months per year and are willing to complete long-term follow-up. long-term follow-up: 1. Diagnosis of sensorineural hearing loss. 2. Bilaterally symmetric hearing with air conduction threshold difference ≤15 dB at 0.5 kHz, 1 kHz, 2 kHz and 4 kHz between two ears. 3. Hearing loss not caused by non-age-related factors.

Exclusion criteria

1. Unable to complete pure-tone audiometry and other auditory examinations. History of central nervous system diseases, including Parkinson's disease, stroke, intracranial tumor or brain trauma. 2. Severe uncontrolled systemic diseases (cardiac, pulmonary, hepatic, renal insufficiency) or advanced malignant tumor with expected survival less than 3 years. 3. Any other condition judged by the investigator inappropriate for study enrollment.

Design outcomes

Primary

MeasureTime frameDescription
Incidence of dementia and cognitive decline, and progression of age-related auditory decline in community-dwelling older adults3 years from baseline enrollmentTo determine the 3-year cumulative incidence of all-cause dementia and cognitive decline, and to assess the progression rate of age-related auditory decline among community-dwelling older adults aged 60 years and above. Based on a multicenter prospective cohort of more than 3000 participants, this primary outcome will clarify the longitudinal association between the deterioration of auditory function and subsequent cognitive impairment and dementia risk, through standardized audiological testing and repeated cognitive function assessment at regular follow-up visits.

Countries

China

Contacts

CONTACTLumeng Han
1345140372@qq.com+8666876060
STUDY_CHAIRShiming Yang

The Medical Ethics Committee of the 6th Medical Center of Chinese PLA General Hospital

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 28, 2026